Quick Summary
Lyntero 150mg Tablet
Last updated on 26 Sep 2026 | 08:41 AM (IST)
₹4693
MRP: ₹8447
(You Save ₹3754)
30 TABLET(s) IN A BOTTLE
44% OFF
₹4693
MRP: ₹8,447.00
Inclusive of all taxes
44% Off
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Olanamo 150mg Tablet
SHIVNAAM TRADEL...
₹ 96.94/tablet
38% cheaper
Zeparib 150mg Tablet
ZEE LABORATORIE...
₹ 99.47/tablet
36% cheaper
Olzapar 150mg Tablet
DELARC PHARMACE...
₹ 133.88/tablet
14% cheaper
Ibyra 150mg Tablet
ZYDUS CADILA
₹ 137.55/tablet
12% cheaper
Better Service Satisfied Customers
Introduction
Lyntero 150mg Tablet contains Olaparib, a PARP inhibitor (Poly ADP-ribose polymerase inhibitor). Lyntero 150 Tablet is used in the treatment of certain cancers, including prostate cancer and metastatic pancreatic cancer. Lyntero 150mg Tablet works by blocking the PARP enzyme that cancer cells use to repair damaged DNA, helping to slow cancer growth and promote cancer cell death.
Lyntero 150mg Tablet uses include targeted therapy for cancers associated with specific genetic mutations, especially in patients who may benefit from PARP inhibition therapy. Lyntero Tablet may be prescribed alone or in combination with other anticancer medicines depending on the patient’s health condition and treatment plan. The dosage and duration of treatment are determined by the treating oncologist.
Before starting lyntero 150 mg, inform your doctor if you have pre existing liver disease, kidney problems, heart conditions, or lung disorders. Regular monitoring may be required during treatment to assess blood counts and organ function.
Lyntero 150mg Tablet is not recommended during pregnancy or breastfeeding because it may harm the unborn baby or nursing infant. Women of reproductive age are usually advised to undergo a pregnancy test before beginning treatment. Men receiving Lyntero 150mg Tablet should avoid sperm donation for at least three months after completing therapy.
Patients searching for Lyntero 150mg Tablet price should note that pricing may vary depending on the pharmacy, location, and availability. If you are considering alternatives to lyntero 150, consult your doctor before making any changes to your cancer treatment plan.
Uses
Lyntero 150mg Tablet uses include:
Treatment of prostate cancer
Treatment of metastatic pancreatic cancer
Used as maintenance therapy after chemotherapy in some cancers
If you’re wondering about Ribaxa 150mg uses, your oncologist will guide you based on your specific cancer type and stage.
How Lyntero 150mg Tablet works
Lyntero 150mg Tablet works by inhibiting the PARP enzyme, a key DNA repair enzyme in cancer cells. By blocking this repair mechanism, Lyntero 150mg Tablet increases cancer cell death, especially in tumours with impaired DNA repair.
This targeted action slows cancer progression and improves survival outcomes in eligible patients.
Interaction of Lyntero 150mg Tablet with Other Drugs
Before starting Lyntero 150mg Tablet, inform your doctor about:
All prescription and non-prescription drugs
Any vitamin supplements or herbal products
Certain medicines may alter the Ribaxa 150mg Composition, increasing the risk of side effects or reducing its effectiveness.
Storage conditions
Store Lyntero 150mg Tablet at room temperature between 20°C to 25°C
Keep it in the original packaging
Protect from moisture, heat, and direct sunlight
Keep out of reach of children
If you miss a dose, skip it if it’s close to your next scheduled dose. Do not double up.
How to take Lyntero 150mg Tablet
Dosage and duration will be decided by your oncologist
Swallow the tablet whole with water
Do not crush, chew, or break the tablet
Take it with or without food, preferably at the same time each day
Your doctor may adjust your dose depending on your response and tolerance.
Safety advice
Pregnancy
Lyntero 150mg Tablet may harm your unborn baby. Inform your doctor if you are pregnant, planning pregnancy, or think you could be pregnant
Breast Feeding
Avoid breastfeeding during and for at least one month after completing Lyntero 150mg Tablet therapy, as it may pass into breast milk.
Lungs
Tell your doctor if you have any lung-related diseases, as Lyntero 150mg Tablet may affect lung function.
Liver
If you have liver problems, inform your doctor before starting Lyntero 150mg Tablet. Dose adjustments may be needed.
Alcohol
The interaction between Lyntero 150mg Tablet and alcohol is not clearly established. It’s best to ask your doctor.
Driving
Lyntero 150mg Tablet can cause dizziness, fatigue, or weakness. Avoid driving or using heavy machinery if you feel unwell.
Side Effects
Like all medicines, Lyntero 150mg Tablet may cause side effects, but not everyone gets them.
Common Side Effects:
Shortness of breath
Nausea
Vomiting
Fatigue
Indigestion
Loss of appetite
Dizziness
Diarrhea
Headache
Serious Side Effects:
Neutropenia (low neutrophil count)
Acute myeloid leukaemia (rare)
Leukopenia (low white blood cells)
Thrombocytopenia (low platelets)
Lung-related issues like inflammation or scarring
If you experience any severe or unusual symptoms, contact your doctor immediately.
Expert Tips
Take Lyntero 150mg Tablet at the same time daily for better treatment consistency.
Stay hydrated and eat a balanced diet to help manage side effects.
Avoid sun exposure; use sunscreen with SPF 50 or more.
Refrain from consuming grapefruit or grapefruit juice, as it may raise Lyntero 150mg Tablet levels in your blood.
Regular blood tests are essential to monitor your blood counts and organ function during treatment.
FAQs
Q1.
What is Lyntero 150mg Tablet used for?
Ribaxa 150mg uses include treating prostate cancer and metastatic pancreatic cancer, often after chemotherapy.
Q2.
Can Lyntero 150mg Tablet be taken during pregnancy or breastfeeding?
No, it’s not recommended during pregnancy or breastfeeding due to potential harm to the baby.
Q3.
Are there any dietary restrictions while using the Lyntero 150mg Tablet?
Avoid grapefruit products, as they can affect the levels of Lyntero 150mg Tablet in your blood.
Q4.
Can Lyntero 150mg Tablet cause low blood cell counts?
Yes, Lyntero 150mg Tablet may lower your red blood cell, white blood cell, and platelet counts. Regular monitoring is advised.
Q5.
Are there any alternatives to the Lyntero 150mg Tablet?
If Lyntero 150mg Tablet alternatives are needed, your oncologist will suggest the most suitable options based on your condition and treatment goals.
Fact Box
Molecule Name | Olaparib |
Therapeutic class | Antineoplastic agents |
Pharmacological class | Poly Adenosine Diphosphate-Ribose Polymerase (PARP) inhibitor |
Indications | 1. Treatment of Prostate cancer 2. Metastatic Pancreatic cancer |
References
Lynparza, United States Food and Drug Administration (USFDA), [Revised on May 2020], [Accessed on March 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208558s014lbl.pdf
AstraZeneca UK Limited, European Medicines Compendium (emc), [Revised on August 2023], [Accessed on March 2024], https://www.medicines.org.uk/emc/files/pil.9204.pdf
AstraZeneca Pharmaceuticals LP, [Revised on November 2023], [Accessed on March 2024], https://den8dhaj6zs0e.cloudfront.net/50fd68b9-106b-4550-b5d0-12b045f8b184/00997c3f-5912-486f-a7db-930b4639cd51/00997c3f-5912-486f-a7db-930b4639cd51_viewable_rendition__v.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Vikas B S
Pharm D
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 26 Sep 2026 | 08:41 AM (IST)
Want to know more?
Read Our Editorial Policy